Paul Saladino· MD
If you have weak mitochondria, you're going to develop a cardiomyopathy, weak heart, you know, either systolic where the heart doesn't squeeze well or diastolic where the heart doesn't relax well.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
If you have weak mitochondria, you're going to develop a cardiomyopathy, weak heart, you know, either systolic where the heart doesn't squeeze well or diastolic where the heart doesn't relax well.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
If you have weak mitochondria, you're going to develop a cardiomyopathy, a weak heart. You know, either systolic where the heart doesn't squeeze well, or diastolic where the heart doesn't relax well.